Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.56 |
| ▸ | FNTA | P49354 | 5/20 | 0.54 |
| ▸ | FNTB | P49356 | 3/20 | 0.54 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.54 |
| ▸ | SQLE | Q14534 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL114886 | 1.00 | KMT2A (0.62) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL114887 | 1.00 | KMT2A (0.62) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL11617759 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL15980322 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL12967956 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL1704911 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL15980978 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL15980982 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL10127135 | 0.98 | KMT2A (0.67) | KMT2AALOX15ALDH1A1MEN1CYP3A4 | |
| SCHEMBL11039524 | 0.86 | SQLE (0.54) | KMT2AALOX15ALDH1A1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3087112-B1 | PROCESSES TO IMPROVE REACTOR STABILITY FOR THE PREPARATION OF ETHYLENE-BASED POLYMERS USING ASYMMETRICAL POLYENES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-01-30 | — | — | EP | disclosed |
| US-9796650-B2 | Inhibitor combination for lithium salt-catalyzed transesterification process and method for removing lithium salt | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-24 | — | — | US | disclosed |
| US-9751964-B2 | Processes to improve reactor stability for the preparation of ethylene-based polymers using asymmetrical polyenes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-09-05 | — | — | US | disclosed |
| US-9718906-B2 | Processes to form ethylene-based polymers using asymmetrical polyenes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-08-01 | — | — | US | disclosed |
| US-20160304643-A1 | PROCESSES TO IMPROVE REACTOR STABILITY FOR THE PREPARATION OF ETHYLENE-BASED POLYMERS USING ASYMMETRICAL POLYENES | DOW GLOBAL TECHNOLOGIES LLC | 2016-10-20 | — | — | US | disclosed |
| US-20160297736-A1 | Inhibitor Combination for Lithium Salt-Catalyzed Transesterification Process and Method for Removing Lithium Salt | DOW GLOBAL TECHNOLOGIES LLC | 2016-10-13 | — | — | US | disclosed |
| US-20150197590-A1 | ETHYLENE-BASED POLYMERS AND PROCESSES FOR THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-07-16 | — | — | US | disclosed |
| WO-2015099915-A1 | INHIBITOR COMBINATION FOR LITHIUM SALT-CATALYZED TRANSESTERIFICATION PROCESS AND METHOD FOR REMOVING LITHIUM SALT | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-07-02 | — | — | WO | disclosed |
| EP-2595642-A2 | COMPOSITIONS COMPRISING DERIVATIVES OF ESSENTIAL OIL COMPOUNDS AND USE IN PERSONAL CARE PRODUCTS | The Procter and Gamble Company (US) | 2013-05-29 | — | — | EP | disclosed |
| WO-2012012385-A2 | COMPOSITIONS COMPRISING DERIVATIVES OF ESSENTIAL OIL COMPOUNDS AND USE IN PERSONAL CARE PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2012-01-26 | — | — | WO | disclosed |
| US-20120014883-A1 | Compositions Comprising Derivatives Of Essential Oil Compounds And Use In Personal Care Products | THE PROCTER & GAMBLE COMPANY | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160297736-A1 | Inhibitor Combination for Lithium Salt-Catalyzed Transesterification Process and Method for Removing Lithium Salt | ADH1C, ADH1A, MAP2K1 | KMT2A 862/4885ALOX15 301/4885ALDH1A1 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.